Pijn bij Kwetsbare Ouderen - NVAM

terug naar de inhoudsopgave– American Geriatrics Society (AGS) Panel on Persistent Pain in Older Persons.The management of persistent pain in older persons. American GeriatricsSociety. J Am Geriatr Soc 2002;50:S205–S224.– American Geriatrics Society (AGS) 'Pharmacological Management of PersistentPain in Older Persons' (2009) Alison B. Altered drug respons in the elderly. Uit:Medicines in the elderly. Pharmaceutical Press London. 1e druk, 2002, 15-27.– American Hospital Formulary Service 2010:2041.– Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin600 mg/d for treating painful diabetic peripheral neuropathy: a doubleblindplacebo-controlled trial. BMC Neurology 2008 8: 33.– Auret K, Schug SA. Underutilisation of opioïds in elderly patiënts with chronicpain: Approaches to correcting the problem. Drugs Aging 2005;22:641–654.– Avouac J, Gossec L, Dougados M. Efficacy and safety of opioïds for osteoartrose:A meta-analysis of randomized controlled trials. Osteoarthr Cartilage2007;15:957–965.– Aw TJ, Haas SJ, Liew D, Krum H. Meta-analysis of cyclooxygenase-2 inhibitorsand their effects on blood pressure. Arch Intern Med 2005; 165:490–496.– Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy andsafety of 5% lidocaïne (lignocaine) medicated plaster in comparison withpregabalin in patiënts with postherpetic neuralgia and diabetic polyneuropathy:interim analysis from an open-label, two-stage adaptive, randomized,controlled trial. Clin Drug Investig. 2009;29(4):231-41.– Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, Asteggiano G.Loss of expectation-related mechanisms in Alzheimer's disease makes analgesictherapies less effective. Pain. 2006 Mar;121(1-2):133-44.– Bijl D. Buprenorfine transdermaal (Transtec®), behandeling ernstige chronischepijn Gebu: 2008(42)2; 18-19– Bijlsma JWJ, Lems WF en van de Laar MAFJ. Nadere plaatsbepaling van coxibsen NSAID’s bij patiënten met nociceptieve pijn. Ned Tijdschr Geneeskd. 2007:7 april;151(14) 795-8– Blandizzi C, Tuccori M, Colucci R, Gori G, Fornai M, Antonioli L, Ghisu N, DelTacca M. Clinical efficacy of esomeprazole in the prevention and healing ofgastrointestinal toxicity associated with NSAID’s in elderly patiënts. DrugsAging 2008;25:197–208.– Bressler R, Bahl JJ. Principles of drug therapy for the elderly patiënt. Mayo ClinProc 2003; 78:1564-1577.– Caldwell JR, Hale ME, Boyd RE, Hague JM, Iwan T, Shi M, LacouturePG.Treatment of osteoartrose pain with controlled release oxycodone or fixedcombination oxycodone plus aceta-minophen added to nonsteroidal antiinflammatorydrugs: A double blind, randomized, multicenter, placebo controlledtrial. J Rheumatol 1999;26:862–869.– Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascularevents and celecoxib: A systematic review and meta-analysis. J R SocMed 2006;99:132–140.– CBO-Richtlijn NSAID-gebruik en preventie, van maagschade, 2003.– CBO-Richtlijn Polyneuropathie, 2005.– Chan MT, Anderson PJ, Chan JC, Lau GS, Critchley JA. Single-dose pharmacokineticsof paracetamol and its conjugates in Chinese non-insulin-dependentdiabetic patiënts with renal impairment. Eur J Clin Pharmacol.1997;52(4):285-8.– Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS,Hui E, Woo J, Sung JJ. Eradication of Helicobacter pylori and risk of pepticulcers in patiënts starting long-term treatment with non-steroidal anti-inflammatorydrugs: A randomised trial. Lancet 2002;359:9–13.– Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, LeeVW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY,Chan HL, Ng EK, Sung JJ.Combination of a cyclo-oxygenase-2 inhibitor and aproton-pump inhibitor for prevention of recurrent ulcer bleeding in patiënts atvery high risk: A double-blind, randomised trial. Lancet 2007;369:1621–1626.multidisciplinaire Richtlijn pijn bij kwetsbare ouderen126